Philadelphia — Philadelphia, Pennsylvania

Philadelphia is a clinical research site located in Philadelphia, Pennsylvania, United States 19102.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Philadelphia has participated in 14 clinical trials with 5 currently active.

Therapeutic areas: Clostridium Difficile Infection (CDI), Heavy Menstrual Bleeding, Uterine Fibroid.

Sponsors: Rebiotix Inc., Myovant Sciences GmbH, Tectonic Therapeutic.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Philadelphia?

Philadelphia has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Philadelphia conducted?

Philadelphia has 14 clinical trials on record, with 5 currently active. Their work covers Clostridium Difficile Infection (CDI), Heavy Menstrual Bleeding, Uterine Fibroid.

Is Philadelphia accredited by Crixeo Health?

Yes — Philadelphia holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Philadelphia?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.